(MENAFN- America News Hour)
The global collagen & gelatin market for regenerative medicine is projected to grow at a CAGR of 10.1% and 7.8% respectively during the forecast period from 2022 – 2031.
The global collagen market for regenerative medicine is projected to grow from USD 420.6 million in 2022 to USD 679.9 million by 2031, at a CAGR of 10.1% during the forecast period. The global gelatin market for regenerative medicine is projected to grow from USD 65.2 million in 2022 to USD 94.9 million by 2031, at a CAGR of 7.8% during the forecast period. The key factors propelling the growth of the global collagen and gelatin market for regenerative medicine include the rising prevalence of chronic diseases, rapid growth in aging population, and growing government & private funding to support the development of regenerative medicine. However, the availability of alternative biomaterials for regenerative medicine is expected to restrain the growth of this market.
“The marine collagen segment is expected to grow at the highest CAGR in the global collagen market for regenerative medicine.”
On the basis of source, the global collagen market for regenerative medicine has been classified into bovine collagen, porcine collagen, marine collagen, and other sources. In 2022, the bovine collagen segment is expected to command the largest share of the global collagen market for regenerative medicine. However, owing to advantages, such as low immunogenicity and high biocompatibility the marine collagen segment is projected to grow at the highest CAGR during the forecast period.
“The orthopedic segment is expected to grow at the highest CAGR in the global collagen market for regenerative medicine.”
On the basis of application, the global collagen market for regenerative medicine has been segmented into orthopedic, wound care, cardiovascular, and other applications. In 2022, the orthopedic applications segment is expected to command the largest share of the global collagen market for regenerative medicine. However, owing to factors such as the rising prevalence of chronic wounds, the wound care segment is projected to register the highest CAGR during the forecast period.
“Asia-Pacific to witness the highest growth during the forecast period.”
North America held the largest share of the collagen market for regenerative medicine and gelatin market for regenerative medicine, while Asia-Pacific is expected to witness the highest growth from 2022 to 2031 in both markets. The high growth in the collagen market for regenerative medicine can primarily be attributed to a large number of CVD patients and diabetics with DFU (diabetic foot ulcers) in the region, the increasing number of research studies, and the increasing focus of industry players on emerging APAC countries. Similarly, the large number of patients suffering from skin burns & brain tumors and the increasing number of research studies in the region are the major factors driving the growth of the APAC market.
Download The Sample PDF Report Here:
The break of primary participants was as mentioned below:
- By Company Type – Tier 1–45%, Tier 2–40% and Tier 3–15%
- By Designation – C-level–41%, Director Level–30%, Others–29%
- By Region – North America–38%, Europe–31%, Asia-Pacific–19%, RoW–12%
The major players operating in the global collagen market for regenerative medicine include Integra LifeSciences Holding Corporation (U.S.), Collagen Matrix, Inc. (U.S.), Collagen Solutions plc (U.K.), Royal DSM (Netherlands), Vornia Biomaterials, Ltd. (Ireland), SYMATESE (France), and NuCollagen, LLC. (U.S.). Similarly, the major players operating in the global gelatin market for regenerative medicine include GELITA AG (Germany), Nitta Gelatin, Inc. (Japan), and PB Gelatin (Belgium).
Research Coverage:
The report analyzes the global collagen and gelatin market for regenerative medicine and aims at estimating market size and future growth potential of this market based on various segments such as source, application, and region. The report also includes an in-depth regulatory analysis for various regions across the globe and competitive analysis of the key players in this market along with their company profiles, product offerings, and recent developments.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned four strategies.
This report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the top players in the global collagen and gelatin market for regenerative medicine. The report analyzes the global collagen and gelatin market for regenerative medicine by source, application, and region
- Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for collagens and gelatins for regenerative medicine across various regions
- Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global collagen and gelatin market for regenerative medicine
- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global collagen and gelatin market for regenerative medicine
Request The Sample PDF Report Here:
About SDKI :
The dynamic nature of the business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count ( SDKI ) provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
MENAFN25092022004545010068ID1104920815
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.